Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present SenesTech, Inc. (NASDAQ: SNES).

Full DD Report for SNES

You must become a subscriber to view this report.


Recent News from (NASDAQ: SNES)

SenesTech, Inc. to Report Third Quarter Fiscal Year 2018 Financial Results on Monday, November 12, 2018
FLAGSTAFF, Ariz. , Nov. 6, 2018 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its third quarter fiscal year 2018, ended September 30, 2018 , af...
Source: PR Newswire
Date: November, 06 2018 09:01
SenesTech Announces Launch of a New Website
FLAGSTAFF, Ariz. , Oct. 29, 2018 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing rat populations through fertility control, announced that it had launched its newly redesigned website at www.senestech.com . The revamped website feature...
Source: PR Newswire
Date: October, 29 2018 09:01
SenesTech To Present at Lytham Partners Virtual Investor Conference
FLAGSTAFF, Ariz. , Oct. 25, 2018 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing rat populations through fertility control, announced today Loretta Mayer , Chair, Chief Executive Officer and Co-Founder of SenesTech, and Tom Chesterman...
Source: PR Newswire
Date: October, 25 2018 16:15
SenesTech Triples Quarterly Sales Over Preceeding Quarter
FLAGSTAFF, Ariz. , Oct. 25, 2018 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing rat populations through fertility control, announced today that preliminary sales for the third quarter of 2018 were approximately triple those of the...
Source: PR Newswire
Date: October, 25 2018 08:31
SenesTech Announces Distribution Agreement with Geotech Supply
FLAGSTAFF, Ariz. , Sept. 5, 2018 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced a distribution agreement for ContraPest® with Geotech Supply Co., LLC ("Geotec...
Source: PR Newswire
Date: September, 05 2018 09:01
SenesTech announces distribution agreement with Agri-Turf Distributing
SenesTech ( SNES ) announced a distribution agreement for ContraPest® with Agri-Turf Distributing, LLC, a pest management distributor based in Santa Fe Springs, California. More news on: SenesTech, Read more ...
Source: SeekingAlpha
Date: August, 16 2018 12:08
SenesTech Announces Distribution Agreement with Agri-Turf Distributing, LLC
FLAGSTAFF, Ariz. , Aug. 16, 2018 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced a distribution agreement for ContraPest® with Agri-Turf Distributing, LLC ("Agri-Tu...
Source: PR Newswire
Date: August, 16 2018 12:02

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-140.71350.72760.7450.71136,197

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1029,96484,35635.5209Short
2018-12-072,0339,33321.7829Cover
2018-12-064,75323,43320.2834Cover
2018-12-042,90125,08811.5633Cover
2018-12-0370010,6256.5882Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SNES.


About SenesTech, Inc. (NASDAQ: SNES)

Logo for SenesTech, Inc. (NASDAQ: SNES)

SenesTech has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company s first fertility control product, ContraPest , is marketed for use in controlling rat infestations. ContraPest s novel technology and approach targets the reproductive capabilities of both sexes, inducing egg loss in female rodents and impairing sperm development in males. Using proprietary bait stations, ContraPest is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rodent communities. ContraPest is designed, formulated and dispensed to be safe for handlers and non target species such as wildlife, livestock and pets, in a biodegradable product. In contrast, the historical approach to managing rodent pest populations, rodenticides, carries a high risk of environmental contamination and the poisoning of non target animals, pets and children. We believe our non lethal approach, targeting reproduction, is more humane, less harmful to the environment, and more effective in providing a sustainable solution to pest infestations than traditional lethal pest management methods. There is currently no other non lethal fertility control product approved by the Food and Drug Administration FDA , or the Environmental Protection Agency EPA , for the management of rodent populations. We believe ContraPest will establish a new paradigm in rodent control, resulting in improved performance in rodent control over rodenticides, without the negative environmental effects of rodenticides. For more information visit the SenesTech website at www.senestech.com.

 

Contact Information

 

 

Current Management

  • Loretta Mayer / CEO

Current Share Structure

  • Market Cap: $5,211,265 - 05/18/2018
  • Issue and Outstanding: 16,512,246 - 03/28/2018

 


Recent Filings from (NASDAQ: SNES)

Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: August, 24 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: August, 24 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 14 2018
Pre-effective amendment to an S-3 filing
Filing Type: S-3/AFiling Source: edgar
Filing Date: August, 14 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: August, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 13 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: August, 03 2018
Prospectus filed under Rule 424(b)(4)
Filing Type: 424B4Filing Source: edgar
Filing Date: July, 26 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: July, 25 2018
Amendment to general form for registration of securities under the Securities Act of 1933
Filing Type: S-1/AFiling Source: edgar
Filing Date: July, 23 2018

 

 


Daily Technical Chart for (NASDAQ: SNES)

Daily Technical Chart for (NASDAQ: SNES)


Stay tuned for daily updates and more on (NASDAQ: SNES)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: SNES)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SNES is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of SNES and does not buy, sell, or trade any shares of SNES. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/